ONYIA JUDE (Chief Scientific Officer) sold 29.9% of their position (11K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $1.76M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/2/2026ACC: 0001894425-26-000012
Officer· Chief Scientific Officer
Since Nov 2021
-11K
Net shares
Net seller
$1.76M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
11K acquired · 22K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+11K
Price / share
$84.74
Trade value
$932.14K
% of position
42.6%
6/1/2026
25.85K→36.85K
Common Stock
Direct
Shares
−11K
Price / share
$160.25
Trade value
$1.76M
% of position
29.9%
6/1/2026
36.85K→25.85K
Total
Net shares
+0.00
Net value
-$830.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2026 | M · Option Exercise | +11K | $84.74 | $932.14K | 42.6% | 25.85K | 36.85K |
| Common Stock Direct | 6/1/2026 | S · Sale | −11K | $160.25 | $1.76M | 29.9% | 36.85K | 25.85K |
| Total | +0.00 | -$830.57K | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
11K shares
Shares
−11K
Strike price
84.74
Held after
13.27K
Exercisable
—
6/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock11K shares | 6/1/2026 | M · Option Exercise | −11K | 84.74 | — | 13.27K |